Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth
Vestibular schwannomas (VSs), the most common tumors of the cerebellopontine angle, arise from Schwann cells lining the vestibular nerve. Pharmacotherapies against VS are almost non‐existent. Although the therapeutic inhibition of inflammatory modulators has been established for other neoplasms, it...
Saved in:
| Main Authors: | Sonam Dilwali, Martijn C. Briët, Shyan-Yuan Kao, Takeshi Fujita, Lukas D. Landegger, Michael P. Platt, Konstantina M. Stankovic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-08-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.molonc.2015.03.009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TIPS AND TRICKS IN SURGICAL TREATMENT OF LARGE VESTIBULAR SCHWANNOMAS
by: Adrian Balasa
Published: (2024-11-01) -
RETROSPECTIVE STUDY OF THE SURGICAL RESULTS IN VESTIBULAR SCHWANNOMA
by: Grigore Zapuhlih
Published: (2024-11-01) -
Retrosigmoid endoscopic keyhole for vestibular schwannomas: Systematic review and meta-analysis
by: Ernesto Enrique Horta-Tamayo, et al.
Published: (2024-04-01) -
Endoscopic third ventriculostomy in hydrocephalus secondary to vestibular schwannomas
by: Ernesto Enrique Horta-Tamayo, et al.
Published: (2023-10-01) -
Vestibular schwannoma: evolution of diagnosis and treatment
by: Sina Radparvar
Published: (2025-01-01)